Literature DB >> 2521222

Binding and activation of plasminogen on immobilized immunoglobulin G. Identification of the plasmin-derived Fab as the plasminogen-binding fragment.

P C Harpel1, R Sullivan, T S Chang.   

Abstract

We have found that tissue plasminogen activator catalyzes the binding of plasminogen (Pg) to immunoglobulin G (IgG) immobilized on a surface. This enhancement is due to the formation of plasmin, since plasmin treatment of immobilized IgG produced a 20-fold increase in Pg binding. Pg binding is lysine site dependent and reversible. The augmentation of Pg binding by plasmin is specific as other proteases produced significantly less or no effect. Immobilized plasmin-treated IgG also specifically binds Pg in plasma. IgG-immobilized Pg is activated by tissue plasminogen activator, and a significant portion of the plasmin formed remains bound to the IgG. The Pg reactive species in a plasmin-treated IgG digest was identified as the Fab fragment by chromatography utilizing the immobilized high affinity lysine-binding site of plasminogen. Specificity of the interaction was further demonstrated by immunoblot-ligand analysis which demonstrated that the plasmin-derived Fab fragment bound Pg whereas papain-derived Fab or plasmin-derived Fc fragments did not. These data suggest that Pg binds to the new COOH-terminal lysine residue of the plasmin-derived Fab. Pg also binds to an immobilized immune complex following plasmin treatment. These findings indicate that surface-bound IgG localizes plasminogen thus extending the spectrum of activity of the plasmin system to immunologic reactions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521222

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Analysis of autoantibodies to plasminogen in the serum of patients with rheumatoid arthritis.

Authors:  M Gonzalez-Gronow; M Cuchacovich; D M Grigg; S V Pizzo
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

2.  Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.

Authors:  P K Anonick; S L Gonias
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

3.  Proteolyzed Variant of IgG with Free C-Terminal Lysine as a Biomarker of Prostate Cancer.

Authors:  Anna Lokshin; Lyudmila M Mikhaleva; Eugene I Goufman; Marina N Boltovskaya; Natalia B Tikhonova; Irina I Stepanova; Alexandr A Stepanov; Natalia V Potoldykova; Andrey Z Vinarov; Paul Stemmer; Vasily Iakovlev
Journal:  Biology (Basel)       Date:  2021-08-23

4.  A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis.

Authors:  Deborah D Crane; Shayna L Warner; Catharine M Bosio
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

5.  Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.

Authors:  Wei-Shiang Lin; Pei-Chih Chen; Cheng-De Yang; EunJung Cho; Bevra H Hahn; Jennifer Grossman; Kwan-Ki Hwang; Pojen P Chen
Journal:  Arthritis Rheum       Date:  2007-05

6.  Angiogenic transforming capacity of IgG purified from plasma of type 1 diabetic patients.

Authors:  Elisa Tramentozzi; Andrea Pagetta; Martina Frasson; Anna Maria Brunati; Monica Montopoli; Paola Finotti
Journal:  J Cell Mol Med       Date:  2008-04-18       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.